MentiNova

About:

MentiNova develops an oral medication to help treat symptoms of Parkinson’s disease.

Website: http://mentinova.com

Top Investors: Foundation Venture Capital Group

Description:

MentiNova Inc., which is developing an oral medication to help treat symptoms of Parkinson’s disease.

Total Funding Amount:

$500000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

New Brunswick, New Jersey, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)mentinova.com

Founders:

Maral Mouradian, Steven Braithwaite

Number of Employees:

1-10

Last Funding Date:

2013-01-28

IPO Status:

Private

Industries: